ask="1.16"
ask_size="200"
average_daily_volume="190361"
bid="1.00"
bid_size="1000"
book_value="0.68"
change="+0.00"
change_from_200_day_moving_average="0.05"
change_from_50_day_moving_average="0.07"
change_from_52_week_high="-0.40"
change_From_52_week_low="0.31"
change_in_percent="+0.00%"
close="1.02"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.27"
ebitda="-15.76M"
eps_estimate_current_year="-0.29"
eps_estimate_next_quarter="-0.01"
eps_estimate_next_year="-0.11"
ex_dividend_date="N/A"
float_shares="44300000"
high="1.04"
high_52_weeks="1.42"
last_trade_date="2/1/2017"
last_trade_price="1.02"
last_trade_size="100"
last_trade_time="4:00pm"
low="1.00"
low_52_weeks="0.71"
market_capitalization="57.56M"
moving_average_200_day="0.97"
moving_average_50_day="0.95"
name="BioLineRx Ltd."
notes="N/A"
one_year_target_price="2.00"
open="1.01"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+5.12%"
percent_change_from_50_day_moving_average="+7.23%"
percent_change_from_52_week_high="-28.17%"
percent_change_from_52_week_low="+43.66%"
previous_close="1.02"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.49"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="56432000"
short_ratio="0.39"
stock_exchange="NCM"
symbol="BLRX"
volume="375945"
weeks_range_52="0.71 - 1.42"
